Read + Share
Terhorst-Molawi D, Hawro T, Grekowitz E, Kiefer L, et al. Anti-KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in
chronic inducible urticaria. Allergy 2023;78:1269-1279.
PMID: 36385701
|
 |
|
Terhorst-Molawi D, Hawro T, Grekowitz E, Kiefer L, et al. Anti-KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in
chronic inducible urticaria. Allergy 2023;78:1269-1279.
PMID: 36385701
|
|
|
|